Pharmafile Logo
Pharmafocus logo
Advanced Search

Manufacturing and Production

Showing 15 posts of 5879 posts found.

laboratory-testing-az

DMD study in vamorolone reports positive results

June 1, 2021 Manufacturing and Production

Santhera Pharmaceuticals and ReveraGen BioPharma have announced positive results from their Phase IIb VISION-DMD study, evaluating the efficacy and safety …
News
baby-2416718_1280

Five-month-old baby receives gene therapy Zolgensma on NHS

June 1, 2021 Manufacturing and Production, Sales and Marketing

A five-month-old baby is one of the first patients to receive Zolgensma, the world’s most expensive drug, on the NHS. …
News

FDA accepts Ipsen’s NDA for ultra-rare genetic disorder drug

June 1, 2021 Manufacturing and Production EMA, FDA, FOP, NDA, ipsen

The FDA have accepted Ipsen’s New Drug Application (NDA) for palovarotene, an oral, investigational, selective RARγ agonist for the prevention …
News

NICE recommends inducing woman in labour earlier than previously advised

May 25, 2021 Manufacturing and Production

In new draft guidance published today NICE has recommended that inducing women in labour earlier than previously advised will make …
News
takeda_usa_pharmaceuticals_u

Takeda: Dengue vaccine successful in long-term trials & set for global distribution

May 25, 2021 Manufacturing and Production EMA, Vaccine, dengue

Japanese pharma company Takeda has announced long-term safety and efficacy results for its dengue vaccine candidate, TAK-003, and has successfully …
News

Man’s eyesight partially restored with optogenetic therapy

May 25, 2021 Manufacturing and Production

A man in France has had his eyesight restored after 20 years of complete blindness, in the first reported case …
News

New research begins on producing HIV treatments in plants

May 25, 2021 Manufacturing and Production

St George’s, University of London has announced a partnership with Leaf Expression Systems to produce HIV treatments in plants. The …
News

CMA to review AstraZeneca’s $39 billion buyout of Alexion

May 25, 2021 Manufacturing and Production

The UK’s Competition and Markets Authority (CMA) is to review AstraZeneca’s $39 billion buyout of US-based Alexion Pharmaceuticals. The COVID-19 …
News

AI software assists in radiographic fracture detection

May 18, 2021 Manufacturing and Production

GLEAMER’s BoneView, an artificial intelligence system, when combined with health professionals’ interpretations, lowered the false negative rate (undetected fractures) on …
News

Sandoz announces €150 million investment in antibiotic production

May 18, 2021 Manufacturing and Production EU, manufacturing, production

Sandoz, a division of Novartis, has announced plans to develop its European antibiotics manufacturing network by expanding the production capabilities …
News
pexels-lucy-6816451_cropped

Asthma drug Dupixent sees positive results in child trials

May 18, 2021 Manufacturing and Production FDA, asthma

Data presented at the 2021 American Thoracic Society International Conference from a Phase III trial of Dupixent (dupilumab) in children …
News

Pfizer-BioNTech vaccine can be kept in fridge longer than previously thought

May 18, 2021 Manufacturing and Production

The EMA has extended the recommended approved storage period for an unopened thawed vial of the Pfizer-BioNTech vaccine from five …
News

Major UK study finds 96% people develop antibodies after one COVID-19 jab

May 18, 2021 Manufacturing and Production

More than 96% of people develop antibodies after just one COVID-19 jab of either AstraZeneca or Pfizer, and almost 100% …
News

Bayer’s cardiovascular drug shows impressive Phase III results

May 11, 2021 Manufacturing and Production Bayer, chronic kidney disease, pharma, pharma news, type 2 diabetes

Bayer’s finerenone drug has been shown to significantly reduce cardiovascular death or other cardiovascular events in patients with chronic kidney …
News
NHS building

Abbvie psoriatic arthritis drug approved for use in Scotland

May 11, 2021 Manufacturing and Production AbbVie, NHS, arthritis, psoriatic arthritis

Abbvie’s RINVOQ (upadacitinib) drug, for the treatment of active psoriatic arthritis (PsA) in adults, has been approved for use in …
News
The Gateway to Local Adoption Series

Latest content

NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma

October 8, 2026

AstraZeneca’s Trixeo approved in EU for asthma

October 8, 2026

Amplio reports early human data for novel methotrexate approach in rheumatoid arthritis

October 7, 2026

Survodutide delivers up to 13.1% weight loss in phase 3 obesity and diabetes trial

October 6, 2026

ESTEVE CDMO adds $17.5m to Illinois expansion

October 6, 2026